Repligen Corp Files 8-K on Financials
Ticker: RGEN · Form: 8-K · Filed: Nov 12, 2024 · CIK: 730272
| Field | Detail |
|---|---|
| Company | Repligen Corp (RGEN) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, operations, sec-filing
TL;DR
Repligen filed an 8-K on Nov 12, 2024, detailing financial results and operations.
AI Summary
Repligen Corporation filed an 8-K on November 12, 2024, to report on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements. The company is incorporated in Delaware and headquartered in Waltham, MA.
Why It Matters
This filing provides crucial updates on Repligen's financial performance and operational status, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine filing reporting financial results and operations, not indicating any immediate or significant new risks.
Key Players & Entities
- REPLIGEN CORP (company) — Registrant
- 41 Seyon Street, Bldg. 1, Suite 100, Waltham, MA 02453 (location) — Principal executive offices address
- November 12, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing by Repligen Corporation?
The primary purpose of this 8-K filing is to report on Repligen Corporation's results of operations and financial condition, as well as to provide Regulation FD disclosures and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 12, 2024.
What is Repligen Corporation's state of incorporation and principal executive office location?
Repligen Corporation is incorporated in Delaware and its principal executive offices are located at 41 Seyon Street, Bldg. 1, Suite 100, Waltham, MA 02453.
What is the SIC code for Repligen Corporation?
The Standard Industrial Classification (SIC) code for Repligen Corporation is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the registrant's telephone number?
The registrant's telephone number is (781) 250-0111.
Filing Stats: 974 words · 4 min read · ~3 pages · Grade level 12.5 · Accepted 2024-11-12 07:44:02
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share RGEN The Nasdaq Global Se
Filing Documents
- d811195d8k.htm (8-K) — 28KB
- d811195dex991.htm (EX-99.1) — 235KB
- d811195dex992.htm (EX-99.2) — 8KB
- g811195ex99_2s10g1.jpg (GRAPHIC) — 67KB
- g811195ex99_2s11g1.jpg (GRAPHIC) — 69KB
- g811195ex99_2s12g1.jpg (GRAPHIC) — 102KB
- g811195ex99_2s1g1.jpg (GRAPHIC) — 45KB
- g811195ex99_2s2g1.jpg (GRAPHIC) — 64KB
- g811195ex99_2s3g1.jpg (GRAPHIC) — 63KB
- g811195ex99_2s4g1.jpg (GRAPHIC) — 66KB
- g811195ex99_2s5g1.jpg (GRAPHIC) — 64KB
- g811195ex99_2s6g1.jpg (GRAPHIC) — 67KB
- g811195ex99_2s7g1.jpg (GRAPHIC) — 64KB
- g811195ex99_2s8g1.jpg (GRAPHIC) — 70KB
- g811195ex99_2s9g1.jpg (GRAPHIC) — 64KB
- g811195g1112075831720.jpg (GRAPHIC) — 5KB
- 0001193125-24-255167.txt ( ) — 1533KB
- rgen-20241112.xsd (EX-101.SCH) — 3KB
- rgen-20241112_lab.xml (EX-101.LAB) — 18KB
- rgen-20241112_pre.xml (EX-101.PRE) — 11KB
- d811195d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release by Repligen Corporation, dated November 12, 2024. 99.2 Supplemental Slides issued by Repligen Corporation, dated November 12, 2024 (furnished herewith). 104 Cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REPLIGEN CORPORATION Date: November 12, 2024 By: /s/ Olivier Loeillot Olivier Loeillot President and Chief Executive Officer